Psoriasis is a chronic, inflammatory multisystem disease that affects up to 3.2% of the US
population. This guideline addresses important clinical questions that arise in psoriasis …

Bronchodilators remain the cornerstone of the treatment of airway disorders such as asthma
and chronic obstructive pulmonary disease (COPD). There is therefore considerable interest …

In this guideline update, we highlight important and new findings related to pharmacological
therapy of chronic obstructive pulmonary disease (COPD) that should change clinical …

Background Long‐acting bronchodilators such as long‐acting β‐agonist (LABA), long‐
acting muscarinic antagonist (LAMA), and LABA/inhaled corticosteroid (ICS) combinations …

Introduction Chronic obstructive pulmonary disease (COPD) is a treatable and preventable
disease characterised by persistent respiratory symptoms and chronic airflow limitation on …

The clinical use of the anticholinergic glycopyrrolate dates back to the early 1960s when it
was first approved in the US Since then, oral and inhalation formulations have been …

Background Inhaled bronchodilators including long-acting beta-agonist (LABA) and long-
acting muscarinic antagonist (LAMA) play a central role in the treatment of stable chronic …

Chronic obstructive pulmonary disease (COPD) has significant contributions to morbidity
and mortality world-wide. Early symptoms of COPD are not readily distinguishable, resulting …

Background: Alzheimer's disease (AD), a major dementia cause, lacks effective treatment.
MRI-based hippocampal volume measurement using artificial intelligence offers new …

Chronic obstructive pulmonary disease (COPD) is characterized by chronic respiratory
symptoms, such as breathlessness and chronic productive cough, limited exercise …